Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically ill patients.

CRRT operates primarily through continuous venovenous hemofiltration (CVVH) and continuous arteriovenous hemofiltration (CAVH). In CVVH, filtration involves positioning a filter between two veins, such as the femoral or jugular veins. This setup often includes a pump to achieve higher filtration rates, thereby enhancing the removal of solutes and fluid. The continuous nature of CVVH allows for a stable balance of fluid and electrolytes, which is crucial for patients with unstable hemodynamics.

Conversely, CAVH uses a filter placed between a femoral artery and a femoral vein. Unlike CVVH, CAVH does not typically require an external pump, as the patient’s arterial pressure drives the filtration process.

A critical parameter in CAVH is the sieving coefficient (S), which quantifies a solute's ability to pass through the membrane. When S equals 1, the solute passes freely through the membrane, whereas an S value of 0 indicates complete solute retention within the plasma. This coefficient is pivotal in determining the efficacy of drug removal during therapy. Additionally, the amount of drug removed can be quantified by integrating the product of clearance and the solute concentration over time.

Both CRRT modalities necessitate vigilant monitoring to ensure optimal performance and patient safety. This includes regular assessment of filter function, fluid balance, and electrolyte levels. Anticoagulation, often with heparin, is commonly employed to prevent clotting within the extracorporeal circuit, maintaining the continuity and efficiency of the therapy.